BioSpace News Archive

Tencent’s WeSure Launched WeFit Program, Invites Netizens to Get up, Get Active and Save with New “WeFit”

WeSure, moves into the health management sector with the launch of the “WeFit” Health Plan (the “Plan”), a new discount-reward scheme inviting WeChat’s 1.1 billion monthly active users to save money and have fun while getting fit.

January 14, 2019
·
3 min read
Business

Mallinckrodt plc To Report Earnings Results For Fourth Quarter And Fiscal 2018

Mallinckrodt Pharmaceuticals announced today that it will report fourth quarter and fiscal 2018 earnings results for the period ending Dec. 28, 2018, on Tuesday, Feb. 26, 2019.

January 14, 2019
·
2 min read
Business

Opsens - Q1 2019 revenues reach a record high of $9.1 M, a 43% increase

Opsens Inc. today reported its results for the first quarter of 2019.

January 14, 2019
·
3 min read
Business

EPIC Insurance Brokers and HR Hotlink Join Forces for the Benefit of California New Car Dealers

EPIC Insurance Brokers and Consultants, a retail property, casualty insurance brokerage and employee benefits consultant, announced today a marketing and distribution agreement with HR Hotlink.

January 14, 2019
·
3 min read
Drug Development

Compugen’s Phase 1 Trial of COM701 Featured as a Trial-in-Progress at The ASCO-SITC Clinical Immuno-Oncology Symposium

Compugen Ltd. today announced that its Phase 1 clinical trial evaluating COM701, a first-in-class therapeutic antibody targeting PVRIG, will be featured in a trial-in-progress poster at The ASCO-SITC Clinical Immuno-Oncology Symposium, taking place February 28-March 2, 2019, in San Francisco, CA.

January 14, 2019
·
3 min read
Genetown

Leap Therapeutics Announces an Investigator-Initiated Study of DKN-01 in Patients with DKK1+ Advanced Prostate Cancer

Leap Therapeutics, Inc. today announced an investigator-initiated study led by David R. Wise, M.D., Ph.D. of the Perlmutter Cancer Center at NYU Langone Health to study DKN-01, as a monotherapy and in combination with docetaxel in patients with advanced prostate cancer.

January 14, 2019
·
5 min read
Deals

Aurora to Acquire Whistler

A Company with an Iconic Brand, Offering Organic Certified Cannabis and Organic Certified Cannabis Derivatives

January 14, 2019
·
9 min read
Biotech Bay

Kindred Biosciences Announces Positive Results from Pilot Field Effectiveness Study of epoCat™ for the Management of Non-Regenerative Anemia in Cats and Availability of Mirataz® at Banfield Pet Hospital

Kindred Biosciences, Inc. today announced positive topline results from its pilot field effectiveness study of epoCat (KIND-510a), a long-acting feline recombinant erythropoietin that is being developed for the management of anemia in cats.

January 14, 2019
·
7 min read
FDA

Amneal Announces Approval of Rivastigmine Transdermal System

The Company is planning to commercialize its Rivastigmine Transdermal System shortly.

January 14, 2019
·
6 min read
Business

AmorChem Invests in Groundbreaking RNA Technology

AmorChem II is proud to announce the closing of its first financing of a university project.

January 14, 2019
·
4 min read